Characterization of the cellular origin of a tissue-engineered human phalanx model by in situ hybridization

被引:3
作者
Chubinskaya, S
Jacquet, R
Isogai, N
Asamura, S
Landis, WJ
机构
[1] Rush Med Coll, Rush Presbyterian St Lukes Med Ctr, Dept Biochem, Chicago, IL 60612 USA
[2] Rush Med Coll, Rush Presbyterian St Lukes Med Ctr, Rheumatol Sect, Chicago, IL 60612 USA
[3] NE Ohio Univ, Coll Med, Dept Biochem & Mol Pathol, Rootstown, OH 44272 USA
[4] Kinki Univ, Dept Plast & Reconstruct Surg, Sch Med, Osakasayama, Japan
来源
TISSUE ENGINEERING | 2004年 / 10卷 / 7-8期
关键词
D O I
10.1089/ten.2004.10.1204
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Tissue-engineered models of human phalanges have previously been fabricated from a combination of bovine periosteum, cartilage, tendon, and biodegradable polyglycolic acid and poly-L-lactic acid scaffolds. Resulting constructs implanted in athymic mice for more than 40 weeks developed new bone, cartilage, and tendon and became vascularized, but cell types comprising the constructs were unidentified. The origin of cells in middle phalanx models implanted for 20 weeks in nude mice has been studied by in situ hybridization analyzing species-specific gene expression. Oligonucleotide probes homologous to species-specific gene sequences of bovine type 11 and X collagen, aggrecan, bone sialoprotein, biglycan, and osteopontin, and mouse decorin were labeled with S-35 and hybridized to respective serial sections of bovine tissue, mouse tissue, and phalanx constructs. In situ hybridization showed positive message and tissue-specific localization for all bovine-specific probes examined within cartilaginous and midshaft portions of constructs and negative message for the mouse-specific decorin probe. These data show that osteoblasts and chondrocytes comprising constructs are derived exclusively from their original bovine sources over 20 weeks of implantation. Defining the cellular origin of the models lends insight into their biological, chemical, and physical nature and their growth and development. Maintenance of their initial genotype is crucial for future application of the models in augmenting impaired human phalanges and related tissues.
引用
收藏
页码:1204 / 1213
页数:10
相关论文
共 15 条
[1]
Aydelotte Margaret B., 1996, Am J Ther, V3, P3, DOI 10.1097/00045391-199601000-00002
[2]
AYDELOTTE MB, 1991, ARTICULAR CARTILAGE, P237
[3]
The role of vascular endothelial growth factor in blood vessel formation [J].
Breier, G ;
Risau, W .
TRENDS IN CELL BIOLOGY, 1996, 6 (12) :454-456
[4]
Chubinskaya S, 1996, LAB INVEST, V74, P232
[5]
*COMM CAR US LAB A, 1985, PUBL US DHEW NIH, V8523
[6]
HUNZIKER EB, 1991, ARTICULAR CARTILAGE, P183
[7]
Formation of phalanges and small joints by tissue-engineering [J].
Isogai, N ;
Landis, W ;
Kim, TH ;
Gerstenfeld, LC ;
Upton, J ;
Vacanti, JP .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1999, 81A (03) :306-316
[8]
Retrovirally mediated expression of decorin by macrovascular endothelial cells -: Effects on cellular migration and fibronectin fibrillogenesis in vitro [J].
Kinsella, MG ;
Fischer, JW ;
Mason, DP ;
Wight, TN .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (18) :13924-13932
[9]
Klagsbrun Michael, 1996, Cytokine and Growth Factor Reviews, V7, P259, DOI 10.1016/S1359-6101(96)00027-5
[10]
MCKEE MD, 1993, CELL MATER, V3, P219